Annexin A5 and anti-annexin antibodies in patients with systemic lupus erythematosus

Rheumatology International

Volumn 32, Issue 5, 2012, Pages 1335-1342

  Hrycek, Antoni ^a,b   Cieślik, Paweł ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b NONE   (Poland)

Author keywords

Annexin A5; Antibodies; Associations; SLE; Therapy

Indexed keywords

ANALGESIC AGENT; ANTI ANNEXIN 5 ANTIBODY; ANTIBODY; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; CHOLESTEROL; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOCORTIN 5; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; QUINAGOLIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT;

EID: 84863624989     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1793-2     Document Type: Article

References (26)

1. Bozic B, Irman S, Gaspersic N, Kveder T, Blaz R (2005) Antibodies against annexin A5: detection pitfalls and clinical associations. Autoimmunity 38:425-430
2. Ulander V-M, Stefanovic V, Masuda J, Suzuki K, Hiilesmaa V, Kaaja R (2007) Plasma levels of annexin IV and V in relation to antiphospholipid antibody status in woman with a history of recurrent miscarriage. Thromb Res 120:865-870
3. Cederholm A, Frostegard J (2005) Annexin A5 in cardiovascular disease and systemic lupus erythematosus. Immunobiology 210: 761-768
4. Cederholm A, Frostegard J (2007) Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population. Ann N Y Acad Sci 1108:96-103
5. Tripathy NK, Sinha N, Nityanand S (2003) Anti-annexin V antibodies in Takayasu's arteritis: prevalence and relationship with disease activity. Clin Exp Immunol 134:360-364
6. Zabek J, Wojciechowska B, Alekberova Z, Reshetniak T, Bier-nacka E, Nasonova V, Karlik W (2003) Anti-annexin V antibodies as a risk factor of thrombotic events and fetal loss in sera of SLE, PAPS and SAPS patients. Reumatologia 41:12-24
7. Esposito G, Tamby MC, Chanseaud Y, Servettaz A, Guillevin L, Mouthon L (2005) Anti-annexin A5 antibodies: are they pro-thrombotic? Autoimmun Rev 4:55-60
8. Marchewka Z (2006) Low molecular weight biomarkers in the nephrotoxicity. Adv Clin Exp Med 15:1129-1138
9. Rand JH, Wu XX, Andree HAM, Ross JBA, Rusinova E, Gas-con-Lema MG, Calandri C, Harpel PC (1998) Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon. Blood 92:1652-1660
10. Bizzaro N, Tonutti E, Villata D, Tampoia M, Tozzoli R (2005) Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages. Arch Pathol Lab Med 129:61-68
11. Asian H, Pay S, Gok F, Baykal Y, Yilmaz MI, Sengul A, Aydin HI (2004) Antiannexin V autoantibody in thrombophilic Behcet's disease. Rheumatol Int 24:77-79
12. Van Heerde WL, Reutelingsperger CPM, Maassen C, Lux P, Derksen RHWM, De Groot PG (2003) The presence of anti-phospholipid antibodies is not related to increased levels of annexin A5 in plasma. J Thromb Haemost 1:532-536
13. Satoh A, Suzuki K, Takayma E, Kojima K, Hidaka T, Kawakami M, Matsumoto I, Ohsuzu F (1999) Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 26:1715-1720
14. Cederholm A, Svenungsson E, Jensen-Urstad K, Trollmo Ch, Ulfgren A-K, Swedenborg J, Fei G-Z, Frostegárd J (2005) Decreased binding of annexin V to endothelial cells: potential mechanism in atherothrombosis of patients with systemic lupus erythematosus. Arter Thromb Vase Biol 25:198-203
15. Su K-Y, Pisetsky DS (2009) The role of extracellular DNA in autoimmunity in SLE. Scand J Immunol 70:175-183
16. Ishikura K, Wada H, Kamikura Y, Hattori K, Fukuzawa T, Yamada N, Nakamura M, Nobori T, Nakano T (2004) High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis. Am J Hematol 76:338-342
17. Cieślak D, Hrycaj P (2007) From apoptosis to autoimmuniza-tion\a new view into the pathogenesis of systemic lupus ery-thematosus. Reumatologia 45:382-385
18. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
19. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
20. Hrycek A (2004) Immunomodulatory properties of prolactin. Pol Arch Med Wewn 112:269-270
21. Rand JH, Wu XX, Quinn AS, Taatjes DJ (2008) Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome. Lupus 17:922-930
22. Shojale M, Sotoodah A, Roozmeh S, Kholoosi E, Dana S (2009) Annexin V and anti-annexin V antibodies: two interesting aspects in acute myocardial infarction. Thromb J 7:13
23. 2-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin Chem 47:1008-1015
24. Kaburaki J, Kuwana M, Yamamoto M, Kawai S, Ikeda Y (1997) Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus. Am J Hematol 54:209-213
25. Nakamura N, Kuragaki C, Shidara Y, Yamaji K, Wada Y (1995) Antibody to annexin V has anti-phospholipid and lupus anticoagulant properties. Am J Hematol 49:347-348
26. Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E (2009) Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Autoimmunity 42:497-506